These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

271 related items for PubMed ID: 11245468

  • 21. Inhibition of tumorigenicity and metastasis of human bladder cancer growing in athymic mice by interferon-beta gene therapy results partially from various antiangiogenic effects including endothelial cell apoptosis.
    Izawa JI, Sweeney P, Perrotte P, Kedar D, Dong Z, Slaton JW, Karashima T, Inoue K, Benedict WF, Dinney CP.
    Clin Cancer Res; 2002 Apr; 8(4):1258-70. PubMed ID: 11948141
    [Abstract] [Full Text] [Related]

  • 22. The Fragile Histidine Triad gene and breast cancer.
    Yang Q, Yoshimura G, Sakurai T, Kakudo K.
    Med Sci Monit; 2002 Jul; 8(7):RA140-4. PubMed ID: 12118213
    [Abstract] [Full Text] [Related]

  • 23. Suppression of tumor growth using a recombinant adenoviral vector carrying the dominant-negative mutant gene Survivin-D53A in a nude mice model.
    Zhu DE, Höti N, Song Z, Jin L, Wu Z, Wu Q, Wu M.
    Cancer Gene Ther; 2006 Aug; 13(8):762-70. PubMed ID: 16543917
    [Abstract] [Full Text] [Related]

  • 24. Effect of fragile histidine triad gene on biologic properties of muco-epidermoid carcinoma cells.
    Liu F, Wu JZ, Li F, Li Y, Li J.
    Cytotherapy; 2008 Aug; 10(7):753-8. PubMed ID: 18985481
    [Abstract] [Full Text] [Related]

  • 25. Prostate-specific expression of Bax delivered by an adenoviral vector induces apoptosis in LNCaP prostate cancer cells.
    Lowe SL, Rubinchik S, Honda T, McDonnell TJ, Dong JY, Norris JS.
    Gene Ther; 2001 Sep; 8(18):1363-71. PubMed ID: 11571575
    [Abstract] [Full Text] [Related]

  • 26. Alterations of the FHIT gene in human hepatocellular carcinoma.
    Yuan BZ, Keck-Waggoner C, Zimonjic DB, Thorgeirsson SS, Popescu NC.
    Cancer Res; 2000 Feb 15; 60(4):1049-53. PubMed ID: 10706123
    [Abstract] [Full Text] [Related]

  • 27. Tumor growth suppression by adenovirus-mediated introduction of a cell-growth-suppressing gene tob in a pancreatic cancer model.
    Yanagie H, Tanabe T, Sumimoto H, Sugiyama H, Matsuda S, Nonaka Y, Ogiwara N, Sasaki K, Tani K, Takamoto S, Takahashi H, Eriguchi M.
    Biomed Pharmacother; 2009 May 15; 63(4):275-86. PubMed ID: 18657378
    [Abstract] [Full Text] [Related]

  • 28. Antitumor activity and bystander effects of the tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) gene.
    Kagawa S, He C, Gu J, Koch P, Rha SJ, Roth JA, Curley SA, Stephens LC, Fang B.
    Cancer Res; 2001 Apr 15; 61(8):3330-8. PubMed ID: 11309289
    [Abstract] [Full Text] [Related]

  • 29. Absence or reduction of Fhit expression in most clear cell renal carcinomas.
    Hadaczek P, Siprashvili Z, Markiewski M, Domagala W, Druck T, McCue PA, Pekarsky Y, Ohta M, Huebner K, Lubinski J.
    Cancer Res; 1998 Jul 15; 58(14):2946-51. PubMed ID: 9679951
    [Abstract] [Full Text] [Related]

  • 30. Cancer gene therapy using a novel secretable trimeric TRAIL.
    Kim CY, Jeong M, Mushiake H, Kim BM, Kim WB, Ko JP, Kim MH, Kim M, Kim TH, Robbins PD, Billiar TR, Seol DW.
    Gene Ther; 2006 Feb 15; 13(4):330-8. PubMed ID: 16195699
    [Abstract] [Full Text] [Related]

  • 31. Bax-induced apoptosis as a novel gene therapy approach for carcinoma of the cervix.
    Huh WK, Gomez-Navarro J, Arafat WO, Xiang J, Mahasreshti PJ, Alvarez RD, Barnes MN, Curiel DT.
    Gynecol Oncol; 2001 Nov 15; 83(2):370-7. PubMed ID: 11606099
    [Abstract] [Full Text] [Related]

  • 32. Reduced acetylated histone H4 is associated with promoter methylation of the fragile histidine triad gene in resected esophageal squamous cell carcinoma.
    Tzao C, Sun GH, Tung HJ, Hsu HS, Hsu WH, Wang YC, Cheng YL, Lee SC.
    Ann Thorac Surg; 2006 Aug 15; 82(2):396-401; discussion 401. PubMed ID: 16863736
    [Abstract] [Full Text] [Related]

  • 33. Components of DNA damage checkpoint pathway regulate UV exposure-dependent alterations of gene expression of FHIT and WWOX at chromosome fragile sites.
    Ishii H, Mimori K, Inageta T, Murakumo Y, Vecchione A, Mori M, Furukawa Y.
    Mol Cancer Res; 2005 Mar 15; 3(3):130-8. PubMed ID: 15798093
    [Abstract] [Full Text] [Related]

  • 34. [Allelic loss and down-regulation of FHIT gene expression in esophageal squamous cell carcinoma].
    Liu FX, Huang XP, Zhao CX, Xu X, Han YL, Cai Y, Wu RL, Wu M, Zhan QM, Wang MR.
    Ai Zheng; 2004 Sep 15; 23(9):992-8. PubMed ID: 15363189
    [Abstract] [Full Text] [Related]

  • 35. In vitro activation of cancer patient-derived dendritic cells by tumor cells genetically modified to express CD154.
    Loskog A, Tötterman TH, Böhle A, Brandau S.
    Cancer Gene Ther; 2002 Oct 15; 9(10):846-53. PubMed ID: 12224026
    [Abstract] [Full Text] [Related]

  • 36. Down-regulation of fragile histidine triad expression in prostate carcinoma.
    Fouts RL, Sandusky GE, Zhang S, Eckert GJ, Koch MO, Ulbright TM, Eble JN, Cheng L.
    Cancer; 2003 Mar 15; 97(6):1447-52. PubMed ID: 12627509
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Loss of FHIT expression in gastric carcinoma.
    Baffa R, Veronese ML, Santoro R, Mandes B, Palazzo JP, Rugge M, Santoro E, Croce CM, Huebner K.
    Cancer Res; 1998 Oct 15; 58(20):4708-14. PubMed ID: 9788626
    [Abstract] [Full Text] [Related]

  • 39. Gene therapy for prostate cancer: toxicological profile of four HSV-tk transducing adenoviral vectors regulated by different promoters.
    Ebara S, Shimura S, Nasu Y, Kaku H, Kumon H, Yang G, Wang J, Timme TL, Aguilar-Cordova E, Thompson TC.
    Prostate Cancer Prostatic Dis; 2002 Oct 15; 5(4):316-25. PubMed ID: 12627218
    [Abstract] [Full Text] [Related]

  • 40. The use of the L-plastin promoter for adenoviral-mediated, tumor-specific gene expression in ovarian and bladder cancer cell lines.
    Peng XY, Won JH, Rutherford T, Fujii T, Zelterman D, Pizzorno G, Sapi E, Leavitt J, Kacinski B, Crystal R, Schwartz P, Deisseroth A.
    Cancer Res; 2001 Jun 01; 61(11):4405-13. PubMed ID: 11389068
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.